Vicore Pharma Holding AB
VCRE
Positions held
Your positionsVCRE isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $248.41M | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | 0.09 | Dividend yield | 0.00% |
| Revenue growth | 26.7% | Earnings growth | — | Gross margin | 100.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -57.0% | ROA | -34.4% | Debt / equity | — |
| Current ratio | 12.68 | Free cash flow | -$282.98M | Analyst recommendation | none | Mean target | $33.27 |
| 52w high | $17.80 | 52w low | $7.88 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2M | $0.6M | $0.4M | — | $1.7M | $0.9M |
| Op margin | -6782.8% | -20572.3% | -31911.0% | — | -6367.2% | -10262.9% |
| Net income | -$143M | -$109M | -$137M | — | -$115M | -$112M |
| Gross margin | 100.0% | 100.0% | 100.0% | — | 100.0% | 100.0% |
| Gross profit | $2.2M | $0.6M | $0.4M | — | $1.7M | $0.9M |
| Operating income | -$150M | -$124M | -$134M | — | -$111M | -$91.5M |
- Revenue +268% vs prior quarter ($2.2M vs $0.6M).
- Gross margin 100% (was 100% prior quarter).
- Operating margin expanded to -6782.8%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.8M | $109M | $0.0M | $0.0M | — |
| Op margin | -11905.8% | -174.1% | — | — | — |
| Net income | -$477M | -$169M | -$311M | -$288M | — |
| Gross margin | 100.0% | 100.0% | — | — | — |
| Gross profit | $3.8M | $109M | $0.0M | $0.0M | — |
| Operating income | -$454M | -$190M | -$321M | -$287M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · Jefferies Initiates Vicore Pharma Holding at Buy With $25 Price Target
2026-09-30 · Increase in Number of Shares and Votes in Vicore Pharma
2026-09-17 · Vicore Pharma to Present in The Stifel 2026 Virtual Immunology and Inflammation Forum
2026-09-01 · Vicore Pharma to Participate in Upcoming Healthcare Conferences
2026-08-26 · Vicore Pharma to Present at The Pareto Securities 17th Annual Healthcare Conference
2026-08-24 · Vicore Pharma to Present at the European Respiratory Society Congress 2026
Price (daily)
Full chart · RSI · MACD · patterns